Common Contracts
14 similar Registration Rights Agreement contracts by Aar Corp, Amylin Pharmaceuticals Inc, Abgenix Inc, others
AAR CORP.Registration Rights Agreement • February 14th, 2008 • Aar Corp • Aircraft & parts • New York
AAR CORP., a Delaware corporation (the “Company”), proposes to issue and sell to the Purchasers (as defined herein) upon the terms set forth in the Purchase Agreement (as defined herein) its 1.625% Convertible Senior Notes due 2014 (the “Securities”). As an inducement to the Purchasers to enter into the Purchase Agreement and in satisfaction of a condition to the obligations of the Purchasers thereunder, the Company agrees with the Purchasers for the benefit of Holders (as defined herein) from time to time of the Registrable Securities (as defined herein) as follows:
AAR CORP. Registration Rights AgreementRegistration Rights Agreement • February 14th, 2008 • Aar Corp • Aircraft & parts • New York
AAR CORP., a Delaware corporation (the “Company”), proposes to issue and sell to the Purchasers (as defined herein) upon the terms set forth in the Purchase Agreement (as defined herein) its 2.25% Convertible Senior Notes due 2016 (the “Securities”). As an inducement to the Purchasers to enter into the Purchase Agreement and in satisfaction of a condition to the obligations of the Purchasers thereunder, the Company agrees with the Purchasers for the benefit of Holders (as defined herein) from time to time of the Registrable Securities (as defined herein) as follows:
Amylin Pharmaceuticals, Inc. Registration Rights AgreementRegistration Rights Agreement • June 8th, 2007 • Amylin Pharmaceuticals Inc • Pharmaceutical preparations • New York
Amylin Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the Purchasers (as defined herein) upon the terms set forth in the Purchase Agreement (as defined herein) its 3.00% Convertible Senior Notes due 2014 (the “Securities”). As an inducement to the Purchasers to enter into the Purchase Agreement and in satisfaction of a condition to the obligations of the Purchasers thereunder, the Company agrees with the Purchasers for the benefit of Holders (as defined herein) from time to time of the Registrable Securities (as defined herein) as follows:
priceline.com IncorporatedRegistration Rights Agreement • September 28th, 2006 • Priceline Com Inc • Services-business services, nec • New York
Goldman, Sachs & Co., As representative of the several Purchasers named in Schedule I to the Purchase Agreement 85 Broad Street New York, New York 10004
AAR CORP.Registration Rights Agreement • February 6th, 2006 • Aar Corp • Aircraft & parts • New York
AAR CORP., a Delaware corporation (the “Company”), proposes to issue and sell to the Purchasers (as defined herein) upon the terms set forth in the Purchase Agreement (as defined herein) its 1.75% Convertible Notes due 2026 (the “Securities”). As an inducement to the Purchasers to enter into the Purchase Agreement and in satisfaction of a condition to the obligations of the Purchasers thereunder, the Company agrees with the Purchasers for the benefit of Holders (as defined herein) from time to time of the Registrable Securities (as defined herein) as follows:
Protein Design Labs, Inc. Registration Rights AgreementRegistration Rights Agreement • February 16th, 2005 • Protein Design Labs Inc/De • Biological products, (no disgnostic substances) • New York
Protein Design Labs, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the Purchasers (as defined herein) upon the terms set forth in the Purchase Agreement (as defined herein) its 2.00% Convertible Senior Notes due 2012 (the “Securities”). As an inducement to the Purchasers to enter into the Purchase Agreement and in satisfaction of a condition to the obligations of the Purchasers thereunder, the Company agrees with the Purchasers for the benefit of Holders (as defined herein) from time to time of the Registrable Securities (as defined herein) as follows:
ABGENIX, INC.Registration Rights Agreement • December 22nd, 2004 • Abgenix Inc • Biological products, (no disgnostic substances) • New York
Abgenix, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the Purchasers (as defined herein) upon the terms set forth in the Purchase Agreement (as defined herein) its 1.75% Convertible Senior Notes due 2011 (the “Securities”). As an inducement to the Purchasers to enter into the Purchase Agreement and in satisfaction of a condition to the obligations of the Purchasers thereunder, the Company agrees with the Purchasers for the benefit of Holders (as defined herein) from time to time of the Registrable Securities (as defined herein) as follows:
Amylin Pharmaceuticals, Inc. Registration Rights AgreementRegistration Rights Agreement • May 10th, 2004 • Amylin Pharmaceuticals Inc • Pharmaceutical preparations • New York
Amylin Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the Purchasers (as defined herein) upon the terms set forth in the Purchase Agreement (as defined herein) its 2.50% Convertible Senior Notes due 2011 (the “Securities”). As an inducement to the Purchasers to enter into the Purchase Agreement and in satisfaction of a condition to the obligations of the Purchasers thereunder, the Company agrees with the Purchasers for the benefit of Holders (as defined herein) from time to time of the Registrable Securities (as defined herein) as follows:
AAR CORP. Registration Rights AgreementRegistration Rights Agreement • February 5th, 2004 • Aar Corp • Aircraft & parts • New York
AAR CORP., a Delaware corporation (the “Company”), proposes to issue and sell to the Purchasers (as defined herein) upon the terms set forth in the Purchase Agreement (as defined herein) its 2.875% Convertible Notes due February 1, 2024 (the “Securities”). As an inducement to the Purchasers to enter into the Purchase Agreement and in satisfaction of a condition to the obligations of the Purchasers thereunder, the Company agrees with the Purchasers for the benefit of Holders (as defined herein) from time to time of the Registrable Securities (as defined herein) as follows:
Bristol-Myers Squibb Company Floating Rate Convertible Senior Debentures due 2023 Registration Rights AgreementRegistration Rights Agreement • November 12th, 2003 • Bristol Myers Squibb Co • Pharmaceutical preparations • New York
Bristol-Myers Squibb Company, a Delaware corporation (the “Company”), proposes to issue and sell to the Purchasers (as defined herein) upon the terms set forth in the Purchase Agreement (as defined herein) its Floating Rate Convertible Senior Debentures due 2023 (the “Securities”). As an inducement to the Purchasers to enter into the Purchase Agreement and in satisfaction of a condition to the obligations of the Purchasers thereunder, the Company agrees with the Purchasers for the benefit of Holders (as defined herein) from time to time of the Registrable Securities (as defined herein) as follows:
K2 Inc. Registration Rights Agreement June 10, 2003Registration Rights Agreement • September 8th, 2003 • K2 Inc • Sporting & athletic goods, nec • New York
K2 Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the Purchasers (as defined herein) upon the terms set forth in the Purchase Agreement (as defined herein) its 5.00% Convertible Senior Notes (the “Securities”). As an inducement to the Purchasers to enter into the Purchase Agreement and in satisfaction of a condition to the obligations of the Purchasers thereunder, the Company agrees with the Purchasers for the benefit of Holders (as defined herein) from time to time of the Registrable Securities (as defined herein) as follows:
Amylin Pharmaceuticals, Inc. Registration Rights AgreementRegistration Rights Agreement • August 14th, 2003 • Amylin Pharmaceuticals Inc • Pharmaceutical preparations • New York
Amylin Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the Purchasers (as defined herein) upon the terms set forth in the Purchase Agreement (as defined herein) its 2.25% Convertible Senior Notes due 2008 (the “Securities”). As an inducement to the Purchasers to enter into the Purchase Agreement and in satisfaction of a condition to the obligations of the Purchasers thereunder, the Company agrees with the Purchasers for the benefit of Holders (as defined herein) from time to time of the Registrable Securities (as defined herein) as follows:
Gilead Sciences, Inc. Registration Rights AgreementRegistration Rights Agreement • March 14th, 2003 • Gilead Sciences Inc • Biological products, (no disgnostic substances) • New York
Gilead Sciences, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the Purchaser (as defined herein) upon the terms set forth in the Purchase Agreement (as defined herein) its 2.00% Convertible Senior Notes due December 15, 2007 (the “Securities”). As an inducement to the Purchaser to enter into the Purchase Agreement and in satisfaction of a condition to the obligations of the Purchaser thereunder, the Company agrees with the Purchaser for the benefit of Holders (as defined herein) from time to time of the Registrable Securities (as defined herein) as follows:
Manpower Inc. Zero Coupon Convertible Debentures due 2021 Registration Rights AgreementRegistration Rights Agreement • October 5th, 2001 • Manpower Inc /Wi/ • Services-help supply services • New York
Goldman, Sachs & Co., Salomon Smith Barney Inc. As representatives of the several Purchasers named in Schedule I to the Purchase Agreement c/o Goldman, Sachs & Co. 85 Broad Street New York, New York 10004
